Literature DB >> 6273773

Identification of the serotype-specific and group-specific antigens of bluetongue virus.

H Huismans, B J Erasmus.   

Abstract

The bluetongue virus (BTV) core particle contains 2 major polypeptides, P3 and P7, and is surrounded by an outer capsid layer that is composed of the 2 major polypeptides, P2 and P5. Analysis of the immune precipitates from soluble 14C-labelled BTV polypeptides and hyper-immune rabbit and guinea-pig sera indicated that polypeptide P2 precipitates only with homologous BTV sera. This would indicate that P2 is the main determinant of serotype specificity. It was also found that in sheep infected with BTV the P2-precipitating antibodies in the serum correlate with the neutralizing antibody titres, whereas the appearance and subsequent decline of P7-precipitating antibodies correspond well with those of the complement fixing antibodies. This suggests that BTV group specificity, as measured by a complement fixation tests, is determined by the core protein P7. This result was supported by the observation that mouse ascitic fluid, which contains a high titre of BTV-specific complement fixing antibodies and a very low titre of neutralizing antibodies, contains almost exclusively antibodies that precipitate P7.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273773

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN: 0030-2465            Impact factor:   1.792


  66 in total

1.  A capsid protein of nonenveloped Bluetongue virus exhibits membrane fusion activity.

Authors:  Mario Forzan; Christoph Wirblich; Polly Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

2.  Evidence of an antigenic shift among Palyam serogroup orbiviruses.

Authors:  Seiichi Ohashi; Youichi Matsumori; Tohru Yanase; Makoto Yamakawa; Tomoko Kato; Tomoyuki Tsuda
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

3.  Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.

Authors:  Jenna Anderson; Emmanuel Bréard; Karin Lövgren Bengtsson; Kjell-Olov Grönvik; Stéphan Zientara; Jean-Francois Valarcher; Sara Hägglund
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

4.  The complete nucleotide and deduced amino acid sequence of the gene encoding the major inner capsid protein, VP7 of US bluetongue virus serotype 17.

Authors:  T F Kowalik; J K Li; R Y Chuang; R H Doi; B I Osburn
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

5.  The proteins expressed in vivo and in vitro by an orbivirus of the Kemerovo serogroup isolated from Ixodes uriae ticks from St. Abb's Head, Scotland.

Authors:  S M Eley; P A Nuttall; N F Moore
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

6.  Complete sequence of bluetongue virus L2 RNA that codes for the antigen recognized by neutralizing antibodies.

Authors:  M A Purdy; H Ghiasi; C D Rao; P Roy
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

7.  Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains.

Authors:  Sushila Maan; Narender S Maan; Piet A van Rijn; René G P van Gennip; Anna Sanders; Isabel M Wright; Carrie Batten; Bernd Hoffmann; Michael Eschbaumer; Chris A L Oura; Abraham C Potgieter; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

8.  RT-PCR assays for seven serotypes of epizootic haemorrhagic disease virus & their use to type strains from the Mediterranean region and North America.

Authors:  Narender S Maan; Sushila Maan; Kyriaki Nomikou; Donna J Johnson; Mehdi El Harrak; Hafsa Madani; Hagai Yadin; Serife Incoglu; Kadir Yesilbag; Andrew B Allison; David E Stallknecht; Carrie Batten; Simon J Anthony; Peter P C Mertens
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

9.  Passive protection of mice and sheep against bluetongue virus by a neutralizing monoclonal antibody.

Authors:  G J Letchworth; J A Appleton
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Development of PCR-based tests for the identification of North American isolates of epizootic haemorrhagic disease virus.

Authors:  M J Harding; I Prud'homme; J Rola; G C Dulac
Journal:  Can J Vet Res       Date:  1996-01       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.